Edition:
United Kingdom

IRIDEX Corp (IRIX.OQ)

IRIX.OQ on NASDAQ Stock Exchange Global Market

8.10USD
17 Aug 2018
Change (% chg)

$0.03 (+0.37%)
Prev Close
$8.07
Open
$8.07
Day's High
$8.20
Day's Low
$8.07
Volume
1,753
Avg. Vol
4,158
52-wk High
$10.35
52-wk Low
$4.78

Latest Key Developments (Source: Significant Developments)

Iridex Announces 2018 Second Quarter Results And Raises Full Year 2018 Guidance
Thursday, 2 Aug 2018 

IRIDEX Corp ::IRIDEX ANNOUNCES 2018 SECOND QUARTER RESULTS AND RAISES FULL YEAR 2018 GUIDANCE.Q2 REVENUE ROSE 3 PERCENT TO $10.3 MILLION.SEES FY 2018 REVENUE $38 MILLION TO $41 MILLION.QTRLY LOSS PER SHARE $0.28.  Full Article

Iridex Issues Voluntary Recall Of Trufocus Lio Premiere Laser Indirect Ophthalmoscope
Friday, 23 Feb 2018 

Feb 23 (Reuters) - Iridex Corp ::IRIDEX ISSUES VOLUNTARY RECALL OF TRUFOCUS LIO PREMIERE™ LASER INDIRECT OPHTHALMOSCOPE.IRIDEX CORP - REVISED ITS PRELIMINARY FINANCIAL RESULTS FOR Q4 AND FULL YEAR ENDED DECEMBER 30, 2017.IRIDEX CORP - RECALLED PRODUCTS WERE MANUFACTURED FROM MAY 26, 2017 TO NOVEMBER 6, 2017 AND DISTRIBUTED FROM JUNE 5, 2017 TO JANUARY 29, 2018.IRIDEX CORP - TOTAL REVENUE FOR Q4 OF 2017 IS EXPECTED TO BE $10.2 TO $10.3 MILLION.IRIDEX CORP - TOTAL REVENUE FOR 2017 IS EXPECTED TO BE $41.5 TO $41.6 MILLION.IRIDEX CORP - COMPANY HAS RECEIVED REPORTS OF THREE ADVERSE EVENTS OCCURRING DURING PROCEDURES IN WHICH TRUFOCUS LIO PREMIERE WAS USED.  Full Article

Societe Quantel Issues Response To Iridex Press Release​
Wednesday, 10 Jan 2018 

Jan 10 (Reuters) - Societe Quantel Sa ::‍QUANTEL ISSUES RESPONSE TO IRIDEX PRESS RELEASE​.‍WE DO NOT ANTICIPATE ANY DISRUPTION TO OUR ONGOING COMMERCIAL PROGRESS​.SAYS BELIEVES ‍IRIDEX'S ACTION IS WITHOUT MERIT​.‍QUANTEL INTENDS TO VIGOROUSLY DEFEND ITSELF AGAINST CLAIMS​.  Full Article

Iridex Corp ‍Filed Lawsuit Against Quantel Medical S.A
Tuesday, 9 Jan 2018 

Jan 9 (Reuters) - Iridex Corp ::IRIDEX CORP - ‍FILED LAWSUIT AGAINST QUANTEL MEDICAL S.A., QUANTEL USA, QUANTEL, S.A. IN U.S. DISTRICT COURT FOR NORTHERN DISTRICT OF CALIFORNIA​.  Full Article

Iridex Corp reports qtrly loss per share $0.27‍​
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - Iridex Corp :Iridex announces 2017 third quarter financial results.Q3 revenue rose 11 percent to $10.9 million.Iridex Corp - ‍Iridex reiterates its previously provided estimate for revenue, and g6 system and g6 probe shipments for full year 2017​.Iridex Corp - qtrly loss per share $0.27‍​.  Full Article

Iridex Q3 preliminary revenues of approximately $9.6 to $9.7 mln
Tuesday, 11 Oct 2016 

Iridex Corp : Iridex announces preliminary revenues for 2016 third quarter . Preliminary revenues of approximately $9.6 to $9.7 million for q3 ended october 1, 2016 . Iridex - while demand for Cyclo G6 laser platform for glaucoma remained strong, revenues of certain retina products were below expectations ."demand for company's new flagship Cyclo G6 laser platform for glaucoma remained strong".  Full Article

BRIEF-Iridex Corp Q1 Revenue $9.5 Million

* REITERATED ITS GUIDANCE FOR 2018 OF G6 PROBE SHIPMENTS OF 40,000 TO 45,000,